KLOW is documented as a four-component blend containing BPC-157, TB-500, GHK-Cu and KPV. Its 80 mg total includes 10 mg KPV alongside the three components listed for the supplied GLOW blend.
The four-component declaration
The supplied KLOW report MA-BLD-0010, revision 01, identifies lot BLD-10-LJT and describes the blend as GLOW plus 10 mg KPV. Read together with the supplied GLOW declaration, this gives the component amounts below.KLOW 80 mg report: MA-BLD-0010, revision 01 (opens in a new tab)GLOW 70 mg report: MA-BLD-0009, revision 01 (opens in a new tab)
| Component | Labelled amount | Reported content |
|---|---|---|
| BPC-157 | 10 mg | 10.02 mg |
| TB-500 | 10 mg | 9.98 mg |
| GHK-Cu | 50 mg | 49.95 mg |
| KPV | 10 mg | 10.00 mg |
Keep the report’s four individual results rather than replacing them with an 80 mg shorthand. They identify which named component each content measurement concerns.KLOW 80 mg report: MA-BLD-0010, revision 01 (opens in a new tab)
A blend needs component definitions
| Field | Reference or document detail |
|---|---|
| Names | KLOW; KLOW Blend |
| Component identity method | LC-HRMS comparison with references |
| Sequence | No single blend sequence; full component sequences are not printed |
| CAS number | No single blend CAS number is specified |
| Molecular formula and weight | A multi-component blend has no single peptide formula or molecular weight |
The KPV addition is a separate identity field. Its short name should remain separate from the TB-500 and copper-complex descriptions. To complete a structural specification, request the sequence, terminal groups and chemical form associated with each named reference.KLOW 80 mg report: MA-BLD-0010, revision 01 (opens in a new tab)
Keep composition and analytical percentages distinct
The report gives peptide-related purity as 99.23% and Cu:GHK as 1.00 mol/mol. The accompanying note defines purity in terms of resolved peptide-related substances, not the proportion of an individual ingredient. Preserve these as separate analytical results.KLOW 80 mg report: MA-BLD-0010, revision 01 (opens in a new tab)
Match the lot and report revision when reviewing a certificate. The declaration, component results and structural information should be retained together so that a later report can be compared field by field.KLOW 80 mg report: MA-BLD-0010, revision 01 (opens in a new tab)
Product and certificate checks
Sources and further detail
- KLOW 80 mg report: MA-BLD-0010, revision 01 (opens in a new tab)
Supplied PDF re-read on 3 October 2026. Identity wording and document-specific results are transcribed; this is not independent authentication.
- GLOW 70 mg report: MA-BLD-0009, revision 01 (opens in a new tab)
Supplied PDF re-read on 3 October 2026. Identity wording and document-specific results are transcribed; this is not independent authentication.
Revised 3 October 2026 using the existing source dossier and the specified primary identity records. Report values describe the linked samples. Products are for laboratory research use only.